Mon-25-05-2015, 10:27 AM
(This post was last modified: Mon-25-05-2015, 10:28 AM by jiml. Edited 1 time in total.)
Hi Bill... You mentioned a patent challenge to Biogen by Kyle Bass over the patent on Tecfidera which expires in 2019 and although we know Tecfidera is not designed for psoriasis. It contains the same active ingredient as Fumaderm, and Psorinovo
I hadn't heard so thanks for the information
I see the challenge is on big pharmaceutical companies that are gaining patents on drugs that Kyle Bass think should never have been given a patent, including Tecfidera as it is a basic drug that has been in use for over 30 years ( just packed in a new tablet.)
I hope he doesn't get paid off by the drug companies to drop the challenge, as he has in the past I have read.....
I hadn't heard so thanks for the information
I see the challenge is on big pharmaceutical companies that are gaining patents on drugs that Kyle Bass think should never have been given a patent, including Tecfidera as it is a basic drug that has been in use for over 30 years ( just packed in a new tablet.)
I hope he doesn't get paid off by the drug companies to drop the challenge, as he has in the past I have read.....